Case Study: 2020 HTA Cohort Company Astarte Medical Partnered With Arkansas Children's On NICUTRITION

Implementing an EMR-integrated Software Solution in the NICU 

Arkansas Children’s Hospital (“ACH”) is a 336-bed, Magnet-recognized facility in Little Rock operating the state’s only Level IV neonatal intensive care unit (NICU) with 104 beds. 

Astarte Medical was fortunate to partner with ACH to implement NICUtrition®, a clinical decision support tool to aid the NICU care team in understanding enteral feeding protocol effectiveness/adherence and in planning enteral feeds for preterm infants. 

NICUtrition solves a huge pain point for clinicians in the NICU, however many hospitals are apprehensive about implementing a new and innovative, yet unproven, software solution – especially one that fully integrates with their EMR. In order to get real world insights, we are conducting interviews with the ACH team and documenting their implementation experience through a series of case studies designed to help inform and alleviate concerns, in particular concerns around the hospital IT resources that are required to implement NICUtrition. 

Background 

Today, infants survive as early as 22 weeks gestational age. As survival rates for extremely preterm infants improve, attention is now being focused on improving the quality of survival. Adequate nutrition early in life is essential in both the physical growth and neurological development of preterm infants. Unfortunately, nutritional inadequacies do not pose an immediate emergency and the urgency to correct deficits becomes a secondary action, leading to growth failure and poor cognitive development over time. 

In spite of accumulating research and increased knowledge of preterm infant nutritional needs, a lack of resources, shared knowledge and time has inhibited the optimization of feeding practices and nutritional management in the NICU, and this remains a major challenge for clinicians. Implementing a standardized feeding strategy has been shown to improve growth outcomes and decrease co-morbidities, but most NICUs are still using paper-based feeding protocols and require dietitians to make manual calculations using pen, paper, and calculator. This manual process 

has been the standard practice for decades. Not only does this manual process provide room for error, but it also creates more work for clinical care teams and is a drain on hospital resources. 

NICUtrition directly interfaces with the hospital’s EMR, whether it’s Epic, Cerner, or other EMRs, and provides an intuitive presentation of feeding, nutrition, and growth-related data. The software digitizes a hospital’s own enteral feeding protocol to monitor compliance and provides real-time feedback with a focus on standardizing and optimizing feeding decisions by the NICU care team. 

Step 1: Retrospective Data Extract 

The first step in the implementation process for the IT team at ACH was a retrospective extract of NICU data. This was needed to establish a baseline of feeding and nutrition metrics for the NICU clinicians. The initial data analysis for ACH was based on three years of historical data on preterm infants under 34 weeks gestational age at birth extracted from Epic. During this three-year historical period, ACH changed protocols twice, therefore all three protocols were digitized and integrated into NICUtrition by the Astarte Medical team. The baseline will help validate the expected benefits of implementing the software such as evaluating protocol adherence, differences in protocols and correlated outcomes, the impact of central line days, parenteral nutrition days, and ventilation days, and understanding what drives length of stay. 

The Role of the BID 

The retrospective data extract was accomplished by utilizing a Business Intelligence Developer (BID) at ACH to map the required data elements and facilitate the data extract and transfer. These data elements included patient information, fluids, parenteral nutrition, growth monitoring, enteral nutrition, contraindications, care events, and neonatal morbidities. The technical difficulty in identifying the data fields was relatively minimal for the BID – it did not require complicated SQL or complex algorithms – the difficulty was finding where the data lives in Epic. 

“I had an excellent experience working with the Astarte Medical team on the implementation of NICUtrition. The learnings from this project,on both sides,will carry over into future projects.”

Steve Chapman, Data Analytics Developer, Clinical BI Developer, Epic Installation Project
Arkansas Children’s Hospital

The BID worked closely with an ACH clinical analyst who was familiar with the hospital’s build of Epic and was also a subject matter expert. The clinical analyst served as the liaison between the BID and the NICU clinical team. The BID estimated only 80-100 hours of time was spent on the retrospective data extract. The nutrition 

fluid management component of this project was new to the BID so there was a learning curve, however he mentioned these learnings will be utilized for future data requests. Through this process the BID and the Astarte Medical team were able to simultaneously confirm flowsheet rows for expected values as well as identify if custom flowsheet rows were used to store the desired data. Much of the information that Astarte Medical requested was in standard, well-documented locations. 

Why Historical Data Is So Valuable 

The ACH NICU clinicians viewed the 3-year retrospective data via the NICUtrition® dashboard with enteral feeding protocol overlay, including comparison of all three protocols and associated adherence and outcomes. This will eventually enable the clinical team to utilize benchmarking filters to do comparative studies and measure the success of new protocols and other quality improvement efforts. NICUtrition® allows them to leverage their EMR investment and conversate directly with the data by asking multi-faceted questions quickly and easily. 

Next Up 

The next step of implementation at Arkansas Children’s will be the prospective integration with Epic on newly admitted preterm infants for real-time, on-demand use of NICUtrition. From a technical perspective, the work performed with the BID to confirm data locations and formats also ensures that in this next step, prospective data will be presented as expected to the clinical team. Our next case study will dive into working with Epic, authentication, FHIR requirements, and lessons learned. 

If you are interested in learning more about NICUtrition, please visit the website or contact sales@astartemedical.com for a demo. 

HEALTHTECH ARKANSAS HEALTHCARE ACCELERATOR TO INTRODUCE FIVE STARTUP COMPANIES SELECTED FOR 2021 PROGRAM WITH VIRTUAL EVENT

OPEN VIRTUAL EVENT, NOVEMBER 2, 2021 at 5:30 PM, FEATURING SECRETARY OF COMMERCE MIKE PRESTON

HealthTech Arkansas, along with 12 healthcare providers —  Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, Northwest Health, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center are hosting a virtual event on November 2, 2021, at 5:30 PM to introduce the five startup companies selected for the 2021 HealthTech Arkansas healthcare accelerator. The event will include a welcome from Arkansas Secretary of Commerce Mike Preston and Patrick Wayte, SVP at the Center for Health Technology and Innovation at the American Heart Association, followed by short presentations from each of the five companies in the cohort.

For the 2021 program, the HealthTech Arkansas accelerator is focused exclusively on companies delivering cardiovascular technologies (devices, digital health and diagnostics), or innovations that can be targeted primarily to cardiac patient populations (e.g. remote patient monitoring). Only applications from companies that met these criteria were considered. 

“Focusing only on cardiovascular technologies concentrates our efforts on a clinical area that’s important to the state of Arkansas and gives us the best opportunity to improve clinical outcomes in our state,” said Jeff Stinson, Director of HealthTech Arkansas. 

Representatives from each of the 12 healthcare providers interviewed applicants and selected companies with technologies that have the potential to advance cardiovascular innovation and cardiac care at their respective organizations. The five companies were selected from high-quality applicants across seven different countries and are headquartered across the world in Switzerland, Israel and the U.S. in California, Washington D.C., and Ohio. The cohort will participate in a program that provides them the opportunity to build solutions specifically identified by Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, Northwest Health, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center as areas of opportunity within their organizations. Each company will receive seed investment as well as complete and total access to clinicians and administrators while executing their pilot projects.

“Over the past three years, working with HealthTech Arkansas to introduce new healthcare technologies to our hospital and to our state has been beneficial not only to our patients but to our staff. We get a chance to see the latest medical innovations, and it helps our own staff to think more innovatively, as well,” said Dr. Gerry Jones, Chief Medical Officer at CHI St. Vincent.

The five companies are:

Hi-D Imaging, Zurich, Switzerland

Hi-D Imaging is an AI imaging software that improves clinical outcomes and decreases pre-operational planning time by providing personalized solutions based on each patient’s anatomy. 

http://www.hidimaging.com/

Moving Analytics, Irvine, CA

Moving Analytics is a virtual cardiac rehab platform that boosts hospital revenues, improves clinical outcomes, and reduces readmissions — even for those hospitals that have existing cardiac rehabilitation programs.

https://www.movinganalytics.com

Lumi Health, Washington, DC

Lumi Health is a remote patient monitoring solution that is AI-driven to better manage medications for heart failure patients, coupled with devices that collect patient biomarkers and an interdisciplinary team that interfaces with patients at home.

http://lumi.health

SoniVie, Tel Aviv, Israel

SoniVie is a proprietary intravascular denervation system using unfocused ultrasound that gives deeper penetration to treat more nerves than competitive RF and other ultrasound-based catheters. The target of their ongoing clinical studies is patients with uncontrolled and resistant hypertension.

https://sonivie.com/

Genetesis, Mason, OH

Genetesis is an FDA-cleared biomagnetic imaging solution that can detect myocardial ischemia in patients with chest pain and other anginal equivalents.

https://www.genetesis.com/

HealthTech Arkansas is a fourth-year accelerator program focused exclusively on provider engagement with early-stage companies and works with both Arkansas-based and out-of-state companies. The Arkansas Economic Development Commission awarded a grant to HealthTech Arkansas through a program designed to increase acceleration activities in targeted industries in the state. 

The virtual event is free and open to the press and the public. Attendees can register for the event at https://bit.ly/HTA2021event. More information about HealthTech Arkansas, including a link to RSVP for the kick-off event, can be found at HealthTechArkansas.com. 

ABOUT HEALTHTECH ARKANSAS

HealthTech Arkansas is an accelerator and early-stage investment fund that recruits worldwide for the most accomplished startups in the areas of digital health, medical devices, and diagnostic platforms. Those companies accepted into the program are guaranteed at least two pilot projects or clinical trials from among 12 leading hospitals, health systems, and physician practices in Arkansas. HealthTech Arkansas is the only program in the U.S. to guarantee pilot projects and clinical trials with healthcare providers. More information can be found atHealthTechArkansas.com.

OMNY Health launches massive integrated dermatology data repository and research network to advance life-changing innovations for patients suffering from skin-related conditions

ATLANTA, June 23, 2021 /PRNewswire/ -- OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation's leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research.  

The assembled longitudinal data represents care delivered over the past five years by over 1,000 dermatologic providers in more than 30 states, across more than 7.5 million unique patients.  OMNY Health works with providers to integrate and standardize their siloed disparate EHR data, enabling the delivery of de-identified data into research-ready subscriptions for Life Sciences organizations, while also delivering insights based on the normalized data back to the data contributors.

At the core of the OMNY Health platform is de-identified, normalized EHR data, further enhanced with tokens that support linkages to data derived from administrative claims, registries and other data resources, while maintaining patient anonymity.   OMNY Health leverages natural language processing (NLP) technology to analyze unstructured data to derive insights often buried in clinician notes, such as adverse drug events, social determinants of health, and reasons for therapy changes. 

"We are excited to partner with these forward-thinking dermatology providers to launch OMNY Health's first suite of specialty databases.   As the number of specialty treatment options expands, OMNY Health provides an ideal platform for delivering scalable data solutions to life sciences companies needing to understand the care delivered by the diverse mix of providers treating patients along their care journey.  Data available on the platform provides the information needed to better understand the patient and provider landscape, design and identify eligible patients for trials, monitor the impact of launch of new therapies in the real-world setting, and evaluate safety and effectiveness of those therapies", said Dr. Mitesh Rao, CEO at OMNY Health.  

Investment in dermatology has experienced double-digit growth over the past several years and is expected to continue to grow, particularly for the conditions falling at the intersection of inflammatory and autoimmune skin disorders, such as alopecia areata, psoriasis, and atopic dermatitis. "We can now address the retrospective and prospective data and analytic needs of life sciences organizations working on treatments for some of the rarest dermatologic conditions, such as epidermolysis bullosa and generalized pustular psoriasis, to common conditions such as acne, and everything in between," said Stacey Long, Chief Strategy Officer, who oversees OMNY Health's product and data science teams.  

"Advanced Dermatology and Cosmetic Surgery, the nation's premier dermatology practice, values our partnership with OMNY. As we actively explore cutting edge therapeutics and leverage our robust data set to find ways to best serve our patients and the dermatology community, a collaboration with an advanced partner, like OMNY is crucial to our long-term success." Allison W. Lynch, Chief Operating Officer, Clinical Research

"We are excited to partner with OMNY Health in looking at real world data. It's an invaluable resource that creates improved patient outcomes, quality metrics, cost efficiencies, and tools for evaluating best practice opportunities. It also allows for prospective research to evaluate new ideas, therapies, and measurement tools that can assist in making better decisions for patients, physicians, payers, and the industry" said Dr. Mark Jackson, Clinical Professor of Dermatology, University of Louisville and Director of Medical/Clinical Research, Forefront Dermatology

Dr. Jackson will join Lawrence Rasouliyan, OMNY Health's Head of Biostatistics and Data Science, on June 24, for a webinar discussion on the vital role of physicians in supporting real-world evidence generation in dermatology and the transformative opportunity for patients, providers, and life sciences organizations. Register at https://omnyhealth.com/events-webinars/register-for-webinar-real-world-data-in-dermatology-why-it-matters/   

About OMNY Health
OMNY Health connects patients, providers, and life sciences companies through data and insights to transform healthcare delivery, improve clinical outcomes, and address patients' unmet needs. For more information go to www.omnyhealth.com or e-mail: lifesciences@omnyhealth.com

SOURCE OMNY Health

Related Links

https://www.omnyhealth.com

INTRODUCING THE FIVE STARTUP COMPANIES SELECTED FOR 2020 PROGRAM

HealthTech Arkansas, Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center hosted a virtual event to introduce the five startup companies selected for the 2020 HealthTech Arkansas healthcare accelerator. 

The event included a welcome from Governor Asa Hutchinson and from Arkansas Children’s Hospital CEO Marcy Doderer, followed by short presentations from each of the five companies in the cohort. Both Ms. Doderer and Governor Hutchinson focused on the importance of working together to bring innovative technologies to Arkansas. Jeff Stinson, director of HealthTech Arkansas introduced the program and discussed its impact on the state.

“While the hospitals in Arkansas have a large economic impact on our state, we’re still a rural state struggling with health equity. We believe innovation in healthcare has significant potential to address the inequities, so we are excited to introduce these five startup companies to Arkansas and the powerful teams available to them at all of our healthcare provider partners around the state,” said Stinson. 

Stinson has worked closely with large accelerator programs across the country to recruit the best applicants for HealthTech Arkansas. As evidence of this effort, Kathryn Zavala, COO of MedTech Innovator based out of Los Angeles, California also spoke at the kick-off event, noting that the collaboration among the 11 providers to support HealthTech Arkansas was unique and a great opportunity for healthcare startup companies. 

“The guaranteed pilot projects from 11 hospitals from around the state are what truly sets our accelerator program apart from others in the country. This is what allowed Arkansas to attract such high-quality companies to the program,” said Stinson.

The five companies are:

Astarte Medical, Yardly, PA

Astarte Medical is a precision nutrition company using software and predictive analytics to improve outcomes during the first 1,000 days of life. With an initial focus on preterm infants, Astarte Medical supports feeding protocols, practice, and decision-making in the neonatal ICU with a suite of digital tools and diagnostics designed to standardize feeding, optimize nutrition and quantify gut health.

https://astartemedical.com/

nView Medical, Salt Lake City, UT

The nView_s1 is an imaging system that provides instant 3D images in the OR with minimal radiation. Like a C-arm, the nView_s1 images from a stationary single position. Unlike a C-arm, novel AI reconstruction techniques allow it to provide 3D images.

http://www.nviewmed.com/

Raydiant Oximetry, San Ramon, CA

Raydiant Oximetry has developed a non-invasive fetal pulse oximeter to directly monitor a fetus’s blood oxygen saturation during labor and delivery and provide the key missing vital sign that clinicians need to more accurately assess the baby’s health during childbirth.

https://www.raydiantoximetry.com/

Vena Vitals, Irvine, CA

Vena Vitals, Inc. is re-innovating the way blood pressure is monitored by using soft stretchable sensors that can conform to the body and accurately measure arterial pulse. Their technology provides the benefits of continuous, beat-to-beat blood pressure measurements, but in a non-invasive way. 

https://evonexus.org/evonexus-companies/vena-vitals/

Zeto, Santa Clara, CA

Zeto has taken a significant step towards simplifying EEG. The Zeto product is the first and only dry electrode EEG headset and cloud platform cleared by the FDA for clinical use. 

https://zeto-inc.com/

The cohort will participate in a program that provides them the opportunity to pilot solutions specifically identified by Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center as areas of opportunity within their organizations, from neonatal health and cardiac care to medical devices and software platforms. Each company will receive seed investment as well as complete and total access to clinicians and administrators while executing their pilot projects.

HealthTech Arkansas is a third-year accelerator program focused exclusively on provider engagement with early-stage companies and works with both Arkansas-based and out-of-state companies. The Arkansas Economic Development Commission awarded a grant to HealthTech Arkansas through a program designed to increase acceleration activities in targeted industries in the state. 

OPEN VIRTUAL EVENT, OCTOBER 5, 2020 at 5:00 PM, FEATURING GOVERNOR ASA HUTCHINSON

HealthTech Arkansas, Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center are hosting a virtual event on October 5, 2020 at 5:00 PM to introduce the five startup companies selected for the 2020 HealthTech Arkansas healthcare accelerator. The event will include a welcome from Governor Asa Hutchinson and Arkansas Children’s Hospital CEO Marcy Doderer, followed by short presentations from each of the five companies in the cohort.

“We are excited to offer a virtual event this year to a broader audience and to introduce the new cohort to Arkansas and the powerful teams available to them at all of our healthcare provider partners around the state,” said Jeff Stinson, director of HealthTech Arkansas. 

The five companies were selected from hundreds of applicants across 14 different countries and are headquartered across the country in California, Utah, and Pennsylvania. The cohort will participate in a program that provides them the opportunity to build solutions specifically identified by Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center as areas of opportunity within their organizations, from heart health and cardiac care to medical devices and software platforms. Each company will receive seed investment as well as complete and total access to clinicians and administrators while executing their pilot projects.

HealthTech Arkansas is a third-year accelerator program focused exclusively on provider engagement with early-stage companies and works with both Arkansas-based and out-of-state companies. The Arkansas Economic Development Commission awarded a grant to HealthTech Arkansas through a program designed to increase acceleration activities in targeted industries in the state. 

The virtual event is free and open to the press and public. Attendees can register for the event at http://bit.ly/hta2020event. More information about HealthTech Arkansas, including a link to RSVP for the kick-off event, can be found at HealthTechArkansas.com.

HEALTHTECH ARKANSAS AND SKYBROOK VENTURE PARTNERS COLLABORATE TO SUPPORT INNOVATIVE HEALTHCARE STARTUPS

HealthTech Arkansas and SkyBrook Venture Partners have agreed to work together, share contacts, and provide opportunities for innovative healthcare startup companies around the world. 

SkyBrook Venture Partners works to elevate awareness of investable companies from Central and Eastern Europe among U.S. investors and other global marketers. HealthTech Arkansas is an accelerator and early-stage investment fund that works to bring innovative healthcare technologies to Arkansas healthcare providers. Together, SkyBrook Venture Partners and HealthTech Arkansas will evaluate any early-stage companies from the SkyBrook client portfolio that might benefit from clinical engagement with Arkansas hospitals and physician practices, as well as work to connect researchers from the SkyBrook network with Arkansas clinicians and researchers for cooperative research and development agreements. 

“Partnering with SkyBrook Venture Partners will expand our ability to find new technologies that can benefit Arkansas healthcare providers, ultimately improving the level of care available in Arkansas,” said Jeff Stinson, director of HealthTech Arkansas. “Our goal is to bring people and innovative thinking to the Arkansas healthcare community that can improve our providers’ operations by improving quality of care, enhance efficiencies, reduce costs, and ultimately grow business opportunities in the state.”

“Through our collaboration with HealthTech Arkansas, we have the opportunity to introduce innovative healthcare solutions companies from around the world to providers that can help them test and grow their businesses with pilot projects or clinical trials in Arkansas,” said Kaja Kuczynska, co-founder for SkyBrook Venture Partners.

HealthTech Arkansas’s 2020 cohort was announced in September 2020 and includes five early-stage companies that are headquartered across the country in California, Utah, and Pennsylvania: Astarte Medical, nView Medical, Raydiant Oximetry, Vena Vitals, and Zeto. The program will kick off in October. The program works with companies in three categories: digital health and software, medical devices, and diagnostic platforms.

ABOUT HEALTHTECH ARKANSAS

HealthTech Arkansas is an accelerator and early-stage investment fund that recruits worldwide for the most accomplished startups in the areas of digital health, medical devices, and diagnostic platforms. Those companies accepted into the program are guaranteed at least two pilot projects or clinical trials from among eleven leading hospitals, health systems, and physician practices in Arkansas. HealthTech Arkansas is the only program in the U.S. to guarantee pilot projects and clinical trials with healthcare providers. More information can be found at HealthTechArkansas.com.

SKYBROOK-small.png

ABOUT SKYBROOK VENTURE PARTNERS

SkyBrook Venture Partners is a company focusing on bridging the gap between the USA and Central/ Eastern Europe. SkyBrook works with American companies that are looking to enter the European market through M&A or JV agreements. Simultaneously they work with American companies that are looking to scale into the region by finding them new clientele and creating R&D opportunities. As for Europe, SkyBrook works closely with companies in the region that are looking to scale outside of their market and can assist them with raising capital, finding clientele, FDA approval, access to clinical research, and much more. They look for the competitive advantages in which they can help clients scale, access new markets, attract investment, and build opportunities. SkyBrook’s extensive work with startups ranges from building three-to-six month incubators all the way to raising multiple series A rounds, for both B2B & B2C startups from all industries. For additional information about Skybrook Venture Partners, visit https://skybrookvp.com/.

FIVE EARLY STAGE COMPANIES SELECTED FOR 2020 PROGRAM

HealthTech Arkansas, along with 11 healthcare providers — Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center — announced the five early-stage companies selected for the 2020 HealthTech Arkansas healthcare accelerator.

Representatives from each of the 11 healthcare providers interviewed applicants and selected companies with technologies that have the potential to advance innovation at their respective organizations. The five companies were selected from hundreds of applicants across 14 different countries and are headquartered across the country in California, Utah, and Pennsylvania. 

“Our provider partners around the state are excited to introduce the new cohort companies to their teams and launch pilot programs that can make a difference in patient care,” said Jeff Stinson, director of HealthTech Arkansas. 

“We’ve expanded the applicant pool and the number of providers in our coalition in each of the three years at HealthTech Arkansas,” said Stinson. “The guaranteed pilot projects and clinical studies from our providers around the state are what differentiates us from any other program in the country.”

The five companies are:

Astarte Medical, Yardly, PA

Astarte Medical is a precision nutrition company using software and predictive analytics to improve outcomes during the first 1,000 days of life. With an initial focus on preterm infants, Astarte Medical supports feeding protocols, practice, and decision-making in the neonatal ICU with a suite of digital tools and diagnostics designed to standardize feeding, optimize nutrition and quantify gut health.

nView Medical, Salt Lake City, UT

The nView_s1 is an imaging system that provides instant 3D images in the OR with minimal radiation. Like a C-arm, the nView_s1 images from a stationary single position. Unlike a C-arm, novel AI reconstruction techniques allow it to provide 3D images.

Raydiant Oximetry, San Ramon, CA

Raydiant Oximetry has developed a non-invasive fetal pulse oximeter to directly monitor a fetus’s blood oxygen saturation during labor and delivery and provide the key missing vital sign that clinicians need to more accurately assess the baby’s health during childbirth.

Vena Vitals, Irvine, CA

Vena Vitals, Inc. is re-innovating the way blood pressure is monitored by using soft stretchable sensors that can conform to the body and accurately measure arterial pulse. Their technology provides the benefits of continuous, beat-to-beat blood pressure measurements, but in a non-invasive way. 

Zeto, Santa Clara, CA

Zeto has taken a significant step towards simplifying EEG. The Zeto product is the first and only dry electrode EEG headset and cloud platform cleared by the FDA for clinical use. 

The cohort will participate in a program that provides them the opportunity to pilot solutions specifically identified by Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center as areas of opportunity within their organizations, from neonatal health and cardiac care to medical devices and software platforms. Each company will receive seed investment as well as complete and total access to clinicians and administrators while executing their pilot projects.

HealthTech Arkansas is a third-year accelerator program focused exclusively on provider engagement with early-stage companies and works with both Arkansas-based and out-of-state companies. The Arkansas Economic Development Commission awarded a grant to HealthTech Arkansas through a program designed to increase acceleration activities in targeted industries in the state.